BlackRock Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$751K Sell
59,959
-135
-0.2% -$1.61K ﹤0.01% 2862
2016
Q3
$832K Sell
60,094
-140
-0.2% -$1.59K ﹤0.01% 2784
2016
Q2
$595K Buy
60,234
+15,056
+33% +$249K ﹤0.01% 2966
2016
Q1
$764K Buy
45,178
+1,005
+2% +$16.2K ﹤0.01% 2663
2015
Q4
$983K Buy
44,173
+285
+0.6% +$7.19K ﹤0.01% 2618
2015
Q3
$1.03M Sell
43,888
-683
-2% -$42.9K ﹤0.01% 2572
2015
Q2
$3.64M Buy
44,571
+25,103
+129% +$2.46M ﹤0.01% 1747
2015
Q1
$1.8M Buy
19,468
+2,362
+14% +$152K ﹤0.01% 2102
2014
Q4
$692K Buy
17,106
+3,783
+28% +$116K ﹤0.01% 2808
2014
Q3
$326K Sell
13,323
-124
-0.9% -$1.97K ﹤0.01% 3154
2014
Q2
$213K Buy
13,447
+69
+0.5% +$997 ﹤0.01% 3228
2014
Q1
$202K Buy
13,378
+958
+8% +$14.9K ﹤0.01% 3230
2013
Q4
$171K Buy
12,420
+756
+6% +$11K ﹤0.01% 3233
2013
Q3
$220K Buy
+11,664
New +$196K ﹤0.01% 3171

Other funds holding ESPR